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Summary. To address traf®cking of transplanted marrow
cells immediately after intravenous infusion, we examined
the early fate of infused non-adherent, low-density donor
bone marrow cells in a syngeneic mouse model. The
presence of infused donor cells, marked with indium-111
oxine (111In), with the ¯uorescent dye PKH26, or by a
detectable transgene marker, was evaluated at 3±48 h in a
variety of tissues, including peripheral blood. All three cell-
marking methods indicated a rapid (<4 h) in¯ux of cells into
the bone marrow, liver, spleen, muscle and other tissues.
Moreover, these tissues remained positive for the 48 h
observation period. Interestingly, analysis of PKH26-positive
cells in non-myeloablated animals demonstrated that
approximately 17% of infused donor marrow cells localized
to the marrow space within 15 h, whereas a smaller
proportion of donor cells (, 1±2%) localized to the
marrow in recipients preconditioned by irradiation. In an
effort to enrich for cells that speci®cally home to the bone
marrow, PKH26-labelled donor marrow cells were recovered
from the ®rst host and infused into a secondary recipient.
Although this was a phenotypically unde®ned population of
cells, no increase was observed in the relative fraction of
PKH26-labelled cells returning or `homing' to the marrow of
the second recipient. Taken together, these data suggest both
that marrow engraftment may be mediated by non-speci®c
`seeding' rather than a speci®c homing signal, and that
ef®cient targeting of transplanted cells to the marrow is a
complex multifaceted process.
Keywords: homing, bone marrow, haemopoiesis, cell migra-
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The remarkable capacity of the bone marrow to regenerate
and reconstitute haemopoiesis provides the rationale for
bone marrow transplantation (BMT). Within a period of
several weeks, infused (donor) stem cells re-establish
haemopoiesis at normal physiologic sites (i.e. the bone
marrow). However, little is known about the early fate of
haemopoietic stem cells following their intravenous admin-
istration until re-establishment of haemopoiesis within the
marrow space. Evidence exists for the involvement of
adhesion molecules such as VLA-4 (Williams et al, 1991;
Rosemblatt et al, 1991; Miyake et al, 1991) and VLA-5
(Rosemblatt et al, 1991) and VCAM-1 (Simmons et al, 1992).
Likewise, proteoglycans such as CD44, CD45 and Mac-1 also
serve as ligands for speci®c adhesion receptors within the
marrow microenvironment (Long, 1992; Coombe et al,
1994). However, these molecules are widely expressed, and
their speci®c role in cellular localization is unclear.
It has been suggested that intravenously infused haemo-
poietic stem and progenitor cells return to the bone marrow
through a speci®c `homing' process (de®ned as the
immediate, selective lodging of haemopoietic cells within
the marrow space) that is mediated by the interaction of cell-
surface receptors with corresponding glyco-conjugate
ligands (Hardy & Tavassoli, 1988; Tavassoli & Hardy,
1990). Moreover, the partial inhibition of BMT ef®ciency
by mannosyl- and galactosyl-neoglycoproteins further
implies that the putative homing receptor contains critical
galactose and mannose residues (Aizawa & Tavassoli, 1988).
In order to characterize the early events of marrow
haemopoietic cell traf®cking following BMT, we monitored
intravenously infused donor bone marrow cells (albeit
phenotypically unde®ned) by three different means:
111Indium labelling, ¯uorescent labelling using the mem-
brane-bound dye PKH26, or the use of a donor-cell-speci®c
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transgene marker detected by PCR. Early traf®cking of
infused donor cells was observed in the marrow of the
recipient mice, as well as in all other tissues examined.
Importantly, signi®cant differences were observed in bone
marrow cell traf®cking for irradiated versus nonirradiated
BMT recipients. Infusion of PKH26-labelled cells that had
localized to the bone marrow of the primary donor into
secondary recipients resulted in a similar tissue distribution
pattern, with no increase in the percentage of cells returning
to the marrow. These results suggest that bone marrow cells
do not speci®cally home to the marrow in the period
immediately following transplantation.
MATERIALS AND METHODS
Bone marrow transplantation. 8±12-week-old male C57BL/6J
mice (Jackson Laboratories) were used for the 111In labelling,
and the PKH26-labelled bone marrow transplantation
studies. Transgenic mice carrying a murine PAI-1 transgene
under control of the cytomegalovirus (CMV) promoter were
used for the transgene-marker PCR studies (Eitzman et al,
1996). Although the original transgenic founder mouse was
SJL/J ´ C57BL/6J, all transgenic mice used in these studies
were the product of more than ®ve backcrosses to the
C57BL/6J parental strain. All mice were maintained under
speci®c pathogen-free (SPF) conditions.
Where indicated, recipient mice were lethally irradiated
with a total dose of 10´5 grays 24 h prior to transplantation
using a 135Cs irradiation source (Gammacell 40, Nordion
International) fractionated into an initial dose of 7 grays
followed by 3´5 grays at 4 h. For the 111In and transgene
marker studies, BMTs were performed by infusion via the tail
vein of 107 nucleated marrow cells into each non-irradiated
or irradiated primary recipient animal. In the case of
secondary transplants (of PKH26-labelled cells, see below),
a total of 5 ´ 105 pooled, marrow cells from the primary
recipient (taken post-irradiation and transplant) were
intravenously administered into irradiated secondary reci-
pients. Donor bone marrow cells were obtained as previously
described (Long & Shapiro, 1985), and red blood cells
(RBC) were removed by incubation with RBC lysis buffer
(145 mM NH4Cl, 10 mM KHCO3 and 0´1 mM EDTA),
followed by washing with phosphate-buffered saline
(PBS).
Labelling of donor bone marrow cells by 111In, and RBC with
technetium-99 (99Tc). Bone marrow NALD cells were isolated
from mouse femurs as described previously (Long & Shapiro,
1986) and labelled with 111In (Medi-Physics Inc., Livonia,
Mich.). For labelling, 111In was added to the cell suspension
and incubated at room temperature for 20 min (Thakur et al,
1977). Labelled cells were washed twice in Hanks' Balanced
Salt Solution (HBSS, from Sigma Chemical Co., St Louis,
Mo.), and resuspended in 1 ml HBSS. During each wash, cells
were collected by centrifugation at 400 g for 7 min at 48C.
After two rinses, the unbound 111In was <8%, and the
labelling ef®ciency was 40%. Cell viability following labelling
was >95%, as measured by trypan blue exclusion. Each of
®ve recipient mice (per time point) received 5 ´ 105 bone
marrow cells carrying approximately 592 kBq of 111In. In
order to determine the amount of 111In label that was due to
blood ¯ow within a given organ (i.e. non-speci®c signal),
RBCs were labelled with 99Tc, using the UltratagÒ kit
(Mallinckrodt Medical, St Louis, Mo.). 1 ml of whole blood
was collected from mice into a syringe containing approxi-
mately 15 units of heparin. The Ultratag kit was prepared
according to the manufacturer's instructions, using the
1 ml of blood and 370 MBq of 99Tc (Nuclear Pharmacy,
University of Michigan Hospital, Ann Arbor, Mich.). The
RBC labelling ef®ciency was determined to be 99%. Each
recipient mouse was given 1´48 MBq of the 99Tc-labelled
RBC mixture, equivalent to 5 ml of donor blood, administered
simultaneously with 111In-labelled NALD cells.
The tissue-speci®c localization index of NALD cells was
calculated by correcting the tissue speci®c 111In signal for
the degree of tissue non-speci®c localization due to the
blood volume within a given organ. The tissue-speci®c 111In
signal was determined by dividing the decay-corrected 111In
counts per gram of a tissue by the 111In counts found
in circulating blood. The relative blood volume within a
given tissue is determined by the ratio of 99Tc counts/g of
tissue to the 99Tc counts/g of blood. The tissue-speci®c NALD
cell localization index was then determined by dividing 111In
tissue/blood counts by 99Tc tissue/blood counts. This calcula-
tion was performed on each tissue from each individual
recipient animal in each group (irradiated and non-irradiated)
and was analogous to the speci®c localization ratio for
antibody targeting (Wahl et al, 1983). Statistical analysis
was performed using Student's t-tests.
Labelling murine bone marrow cells with PKH26. Cell
labelling with PKH26, a ¯uorescent membrane dye, was
performed according to the manufacturer's instructions
(Sigma, St Louis, Mo.). To de®ne the optimal conditions for
labelling murine bone marrow cells, PKH26 concentrations
of 2, 5, 10 and 20 mM were tested. Dye concentrations of
>2 mM were associated with signi®cant fractional cell death
as assayed by trypan blue exclusion. Optimal labelling was
obtained following incubation of 1±5 ´ 107 marrow cells/ml
in 2 mM PKH26 for 2 min at room temperature.
Flow cytometric analysis of PKH26-labelled bone marrow
samples. Bone marrow cells of recipient animals were
harvested from both femurs at various time points following
injection. After removal of RBCs by osmotic lysis, bone
marrow samples were ®xed with 1% paraformaldehyde in
PBS for analysis using a Coulter Epics Elite Flow Cytometer
(Coulter Corporation, Hialeah, Fla.) with an excitation
wavelength of 514 nM and an emission wavelength of
575 nM. The following formula was used to calculate the
seeding ef®ciencies (SE) of infused donor marrow cells: SE
(%) (PK ´ TM/TD) ´100, where PK the percentage of
PKH26-positive cells in the recipient marrow sample as
determined by FACS analysis; TM the number of nucleated
marrow cells in the total marrow space of the recipient
mouse; this number was estimated to be 1´7 ´ 108 for non-
irradiated and 1´7 ´ 106 for irradiated hosts, based on
average cell counts of both femurs from ®ve animals, and
assuming each femur to contain 6% of total marrow
(Chervenick et al, 1968) and TD total number of infused,
PKH26-labelled donor cells.
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DNA extraction and PCR ampli®cation to detect donor cells.
Femoral marrow cells and peripheral blood, along with
sections of liver, lung, spleen and kidney, were collected from
euthanized recipient mice, and total cellular DNA was
prepared using standard methods (Sambrook et al, 1989).
PCR primers (50CCACAACTAGAATGCAGTGA30 and
50CCTACACAACGAAGAGGTCC30) were designed to amplify
a 290 bp segment of vector-speci®c sequence within the PAI-1
transgene. PCRs were performed (Kakuta et al, 1986)
using 200 ng of each primer in a volume of 50 ml for 35
cycles. The PCR product was visualized by ethidium bromide
staining after electrophoresis in 4% NuSieve agarose gels
(FMC Bio Products, Rockland, Maine). Negative control
reactions (no added DNA template) were routinely included.
These control lanes were consistently negative for all PCR
experiments.
RESULTS
Detection of donor cells in various tissues by 111In labelling
The tissue-speci®c localization (TSL) of bone marrow derived
non-adherent low-density (NALD) cells following transplan-
tation of 111In and 99Tc-labelled cells is shown in Figs 1 and
2. A speci®c signal was detected in all tissues examined, but a
number showed relatively low degrees of tissue localization.
These include kidney, heart, skeletal muscle, fat and small
intestine (latter two not shown). None of the localization
signals in these ®ve tissues were signi®cantly different from
each other (P < 0´05). In contrast, tissues with a known
predilection for accumulating labelled granulocytes (Thakur
et al, 1977) showed increased cellular localization of
(granulocyte-depleted) NALD cells. For the non-irradiated
recipients, signi®cant NALD cell localization (compared to
the relatively low localization to the heart; so chosen as the
heart had an intermediate absolute localization signal of the
aforementioned `low-localization' tissues) was seen in bone
marrow, spleen and liver 4 h following the injection (Fig 1,
upper panel). At 24 h, there was a continuing rise in NALD
cell traf®cking in most tissues (Fig 2, upper panel, note
difference in Y-axis scale). In the irradiated recipients,
Fig 1. Tissue-speci®c localization of donor bone marrow cells 4 h
following administration. Murine non-adherent low-density (NALD)
bone marrow cells were collected from donor animals and labelled
with 111In, and donor red blood cells were labelled with 99Tc as
described in Methods. 4 h following simultaneous intravenous
administration of both cell types into non-irradiated (upper panel)
and irradiated (lower panel) hosts, tissue samples were obtained
from euthanized animals, and the tissue-speci®c localization index
calculated as described in Methods. * P < 0´05 compared to the
myocardium.
Fig 2. Tissue-speci®c localization of donor bone marrow cells 24 h
following administration. Tissue samples were taken, and tissue-
speci®c localization index determined, at 24 h following administra-
tion. Details as in Fig 1.
speci®c localization (in excess of that occurring in the heart)
occurs within 4 h, and was seen in a variety of tissues: bone
marrow, spleen, kidney, liver and lung (Fig 1, lower panel).
These tissues also continued to show signi®cant localization
at 24 h, though the relative accumulation of labelled cells
is markedly increased (Fig 2, lower panel, note change in
Y-axis scale). Comparison of 4 h and 24 h data indicated
that signi®cant increases in tissue localization occurred in
both `haemopoietic' tissues (bone marrow, spleen and liver)
and in non-haemopoietic tissues (kidney, lung, heart and
muscle; compare Figs 1 and 2). However, the magnitude of
the change in TSL was not greatly different between these
two types of tissue, and was often equivalent or higher in
non-haemopoietic tissues. Taken as a whole, the TSL data
indicate that intravenously injected NALD cells showed no
speci®city for haemopoietic microenvironments (or micro-
environments with haemopoietic potential) during the ®rst
24 h following infusion.
PCR detection of infused bone marrow cells in multiple tissues
For these experiments, donor bone marrow cells were
harvested from a transgenic mouse line carrying an inert
PAI-1 transgene. Host animals were killed at varying times
following transplantation, and tissue samples (from blood,
marrow, liver, lung, spleen and kidney) were examined by
PCR using oligonucleotide primers speci®c for transgene
sequences. As with the 111In/99Tc studies, a transgene signal
was obtained from bone marrow, peripheral blood, liver and
spleen DNAs at all time points (Fig 3), with similar signals
also observed in lung and kidney (data not shown). A
constant signal was evident at later time points in bone
marrow and spleen DNA, demonstrating that a persistent
proportion of donor cells was localized in these two tissues
(Fig 3), whereas the signal from liver and blood diminished
somewhat after 20 h. The decreased signal from blood was
consistent with a continued gradual migration of donor cells
out of the peripheral circulation, and suggests that donor
marrow cells rapidly leave the circulation following infusion,
migrating into multiple organs and tissues.
PKH26 labelling of murine bone marrow cells
The PKH26 dye stably and irreversibly labelled the lipid
component of the cell membrane for a broad range of cell
types, without signi®cant exchange between cells, and
without apparent interference with cellular function or
surface protein structure (Slezak & Horan, 1989; Samlowski
et al, 1991; Ricketts et al, 1992). In addition, Hendrikx et al
(1996) demonstrated that the presence of the PKH26 dye did
not interfere with the formation of day 8 and day 12 spleen
colonies in lethally irradiated mice.
Bone marrow from recipient mice was collected at 15, 25
and 40 h post transplantation, and analysed for the presence
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Fig 3. Detection of DNA from bone marrow cells in the recipient
blood, bone marrow, spleen and liver by PCR. The 290 bp PCR
product ampli®ed from the PAI-1 transgene is a speci®c marker for
donor cells. The number at the top of each lane shows the time (h)
post-transplantation at which the samples were taken.
Fig 4. Detection of PKH26 labelled donor bone marrow cells by ¯ow
cytometric analysis in bone marrow samples obtained from recipient
mice. Samples collected 15 h after marrow infusion. (A) Donor cells.
(B) Non-irradiated recipient. (C) Irradiated recipient. Dashed line,
auto¯uorescence (i.e. background ¯uorescence); solid pro®les,
PKH26 ¯uorescence.
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of PKH26-labelled cells by ¯ow cytometry. A typical analysis
of recipient mice is shown in Fig 4. The results of the analysis
at the 15 h time point in non-irradiated recipients are shown
in Fig 4B. Based on the numbers of infused donor cells and
total host marrow cells, we calculated that approximately
17% of the infused donor cells (Table I) localized to the bone
marrow of non-irradiated recipients within 15 h following
injection. Though a larger ¯uorescence peak was seen at
15 h in irradiated mice (Fig 4C), compared to the similar
experiments in non-irradiated hosts (Fig 4B), this was due to
the marked decrease in the number of unlabelled host cells
following irradiation. Calculations based on correction for
numbers of unlabelled host cells indicated that approxi-
mately 3% of the infused donor cells localized to the marrow
of irradiated recipients (Table I). For both groups of animals,
maximal localization of infused cells to the marrow appeared
to have been reached by the ®rst time point (15 h), with no
signi®cant changes in the percentage of cells localizing to the
marrow at up to 40 h (data not shown).
Within 15 h of transplantation, signi®cant differences in
donor-cell ¯uorescence intensity were seen in irradiated
versus non-irradiated recipients (compare Figs 4B and 4C).
In non-irradiated animals approximately 65% of the donor
cells retain PKH26 staining equivalent to that of the input
cells, whereas ¯uorescent intensity of the remaining 40% of
cells was reduced by approximately one-half the original,
which suggested that these cells had completed approxi-
mately one round of cell division. In contrast, the donor cells
detected in irradiated recipients (Fig 4C) exhibited ¯uores-
cent intensities of one-quarter to one-half that of input cells,
demonstrating a greater degree of donor cell proliferation in
these animals.
Failure of bone marrow localization to enrich for a speci®c
`homing' subpopulation
In an effort to enrich for a subpopulation of donor cells
capable of speci®cally homing to the recipient marrow, cells
localized to the bone marrow in the ®rst transplant recipient
were collected and infused into secondary recipient animals.
For these experiments, PKH26-labelled cells were ®rst
injected intravenously into an irradiated primary host, and
unfractionated bone marrow cells were collected from the
femurs of recipient animals 15 h following the ®rst
transplant. These cells were then intravenously infused
into irradiated secondary recipients. The secondary recipi-
ents were killed at 15 h, and femoral bone marrow cells were
collected. Flow cytometric analysis of bone marrow cells
from the secondary recipient detected only very small
numbers of PKH26-labelled cells derived from the original
donor animal (<0´1%). Calculations of seeding ef®ciency
(Table I) indicated that < 3% labelled cells isolated from the
marrow of the ®rst recipient again localized to the marrow in
the secondary recipient. This value did not represent a
signi®cant enrichment over the fraction of cells that localized
to the primary recipient marrow. Thus, cell migration to the
bone marrow of the primary transplant recipient failed to
enrich for a subpopulation of cells capable of again
speci®cally homing to the marrow of the secondary recipient.
Analysis of experiments using non-irradiated primary and
secondary recipients similarly failed to demonstrate signi®-
cant enrichment of a speci®c homing subpopulation. To
some degree, however, the high background of unlabelled
cells could have obscured detection of marrow enrichment in
these latter experiments. Also a formal possibility remains
that, at 30 h post labelling, the PKH26-marked cells
proliferated (in irradiated recipients) to a degree that their
¯uorescence-intensity was close to background and thus the
cells were undetectable as originally labelled cells. We believe
that this is unlikely, given the high ¯uorescence intensity of
the PKH26-labelled cells (Fig 4A), and the data showing that
the majority of cells undergo a single population doubling
(Fig 4C). Thus, even three population doublings would yield
a signal well above background (i.e. one-eighth that of
original, within the second decade of the ¯uorescence
histogram).
DISCUSSION
The localization of infused donor cells to the host marrow is a
critical component of BMT engraftment, and the reconstitu-
tion of host haemopoiesis. A number of laboratories have
presented data to support the existence of a speci®c homing
receptor on the haemopoietic stem cell, with a corresponding
ligand being present on the marrow endothelial cell and/or
the marrow stroma. Our observations, demonstrating early
localization of up to 17% of infused donor cells to the
marrow of non-irradiated recipients, suggest that a broad
range of phenotypically unde®ned bone marrow cells are
Table I. Localization of PKH26-labelled cells to the bone marrow at 15 h.
Total marrow Labelled cells Seeding
% Labelled cells cellularity infused ef®ciency (%)
Condition (PK) (TM) (TD) (SE)
Primary recipient
Non-irradiated 1´0 1´7 ´ 108 1 ´ 107 17´0
Irradiated 10´0 1´7 ´ 106 1 ´ 107 1´7%
Secondary recipient
Irradiated <0´1 1´7 ´ 106 5 ´ 104 <3´4
Seeding ef®ciency was calculated as described in Materials and Methods.
capable of initially localizing to the marrow, as well as other
organs. The subsequent failure to enrich for a homing
subpopulation in the secondary serial transplant was
unexpected, and argues against the existence of a speci®c,
highly ef®cient, `homing' mechanism. Thus, the analysis of
early NALD cell traf®cking using both 111In labelling and
PCR detection of a marker transgene demonstrated that,
within as little as 3 h, injected cells leave the circulation and
migrate into a diverse number of organs and tissues in an
apparently nonspeci®c pattern. Other PKH26-labelling
studies, utilizing more puri®ed subpopulations of haemo-
poietic cells, showed a similar temporal movement (i.e.
within 3 h) of haemopoietic stem and/or progenitor cells into
the bone marrow or spleen (Lanzkron et al, 1999; Szilvassy
et al, 1999). However, these investigations did not monitor
cell traf®cking into other (non-haemopoietic) tissues. Inter-
estingly, the NALD cell tissue distribution pattern observed in
our study was very similar to that seen by the infusion of
111In-labelled autologous peripheral blood leucocytes in
humans, where the spleen, liver, lungs and marrow
represent the site of greatest tracer (cell) accumulation
(Thakur et al, 1977). This suggests that general mechanisms
of vascular egress regulate the early events of phenotypically
unde®ned marrow cell traf®cking following intravenous
infusion.
The increased uptake of 111In-labelled NALD cells to a
variety of tissues in irradiated mice relative to non-irradiated
animals is probably due to the increase in general vascular
permeability seen following total body irradiation of this
magnitude (i.e. capillary leak) (Vriesendorp et al, 1994;
Aizawa & Tavassoli, 1988). Although the subset of PKH26-
labelled cells from the original donor detected in the
secondary recipient by FACS analysis (<0´1%) was near
the limit of sensitivity for this assay, the predicted signi®cant
increase in the percentage of speci®c homing cells was not
observed. However, we cannot exclude the existence of a
small subpopulation of cells (e.g. stem cells) which does
ef®ciently home to the marrow, but was obscured by the
nonspeci®c movement of the large background of other
marrow cells.
Consistent with a recent report of utilizing PKH26
labelling (Hendrikx et al, 1996), we observed higher
numbers of PKH26-labelled donor cells in the marrow of
non-irradiated recipients than in irradiated animals. How-
ever, unlike that study, we observed a majority of cells in non-
irradiated hosts that remained quiescent, whereas 40%
underwent proliferation. The reason for the difference
between these two studies is not clear, but may be related
to the 5-fold differences in PKH26-labelling concentration,
or other technical variations. Moreover, Hendrikx et al
(1996) utilized an antigenically de®ned population of cells
enriched in stem cell activity whereas our study employed
non-adherent low-density cells. This latter cell population
consists of >99% lymphoid cells and contains very
few mature myeloid cells that would readily egress into
tissues and represent a `false positive' signal. This difference
in cell populations undoubtedly accounts for the locali-
zation differences. However, it is interesting to note the
similarities in traf®cking: both populations performed better
in non-myeloablated recipients, and both showed evidence of
cell traf®cking into organs other than the marrow.
Our intent was to examine the traf®cking of bone marrow
NALD cells to determine if localization speci®city or
transplant-mediated enrichment could be observed at this
level of `resolution', and this was not the case. Hendrikx et al
(1996) also noted a (calculated) speci®c localization index
for cells localizing to the marrow, that was higher than that
of cells localizing to the spleen, suggesting that speci®c
`homing' had occurred, especially for the enriched popula-
tion of cells used in that study. However, their study also
observed cells in the liver, demonstrating that cells also
localized to this tissue. Given that the sensitive PCR and
indium-labelling studies reported here showed a rapid egress
to all tissues, and that the secondary bone marrow
transplant of labelled cells failed to speci®cally enrich a
population of donor cells, we believe that non-speci®c tissue
migration plays a previously unappreciated role in early
haemopoietic cell traf®cking.
Our data are consistent with a number of investigations
suggesting that no preferential selection of haemopoietic
cells occurs within the bone marrow. Papayannopoulou et al
(1995) demonstrated that selective modulation of bone
marrow cell traf®cking (at 3 h) was mediated by the VLA4/
VCAM-1 integrin system, but that other cytoadhesion
molecules also played a role in bone marrow localization.
Their observations, in turn, were in agreement with earlier
studies that reported the presence of haemopoietic progeni-
tor cells in many tissues (lung, liver, kidney, spleen, blood and
bone marrow) shortly following cell infusion into irradiated
recipients (Vos et al, 1972; Kretchmar & Conover, 1969;
Lahiri & Van Putten, 1969). Our data con®rm and extend
these observations indicating that donor bone marrow cells
localize to most tissues, for periods of up to 48 h following
infusion. Taken together, these investigations argue against
the preferential uptake of haemopoietic cells by the bone
marrow. None of these studies, however, distinguish between
the preferential retention of haemopoietic progenitor cells in
haemopoietic tissues (after 48 h), or a preferential survival
and proliferation within a haemopoietic microenvironment.
Myeloablation is assumed to be a necessary prerequisite
for bone marrow transplantation that ensures removal of
host cells and the creation of appropriate niches for
engrafting donor cells (Scho®eld, 1978; Takada et al,
1971; Micklem et al, 1968). However, several studies have
shown that donor cells are capable of stable engraftment,
even without prior chemotherapy, or radiation (Takada et al,
1971; Brecher et al, 1979; Micklem et al, 1968; Quesenberry
et al, 1994), suggesting that marrow spaces (`niches') do not
have to be created to ensure engraftment. Our PKH26-
labelling data and that of Hendrikx et al (1996) suggest that
immediate traf®cking of infused bone marrow cells to the
marrow space is inhibited by prior radiation, possibly due to
damage to the marrow sinusoidal endothelial cells, or
damage to other components of the haemopoietic micro-
enviroment. The 111In-labelling studies con®rmed this
concept, showing increased tissue speci®c localization in a
number of tissues that was similar to cell-distribution
patterns observed when 111In-labelled granulocytes were
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infused (Thakur et al, 1977). We conclude that an early
adverse affect of irradiation might not be appreciated in the
standard stem cell transplant protocols, as successful
engraftment generally is not assessed until a much later
time point.
Based on the above data, we hypothesize that the early
migration of infused marrow cells may represent nonspeci®c
`seeding' rather than a speci®c homing process. Infused
marrow cells, at many stages of differentiation, may ®rst
adhere to vascular endothelial cells, and exit the circulation
nonspeci®cally into many tissues. In this model, infused
marrow cells would be distributed to all tissues randomly, but
only those within the bone marrow would encounter the
appropriate environment for proliferation and differentia-
tion. Though this model is consistent with our observations
of phenotypically unde®ned marrow cell traf®cking at early
time points, we cannot exclude a more complex speci®c
homing process requiring prior cell processing in other
tissues, or later changes in the cell surface, to selectively
localize cells to the marrow. We conclude that bone marrow
cell traf®cking is a complex multifaceted process, and that
the ef®cient targeting of transplanted cells to the marrow
cannot be explained by a simple single receptor/ligand
interaction.
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